News

Melbourne, Australia, and San Francisco, USA, Sept. 19th, 2017 – Telix Pharmaceuticals Limited (“Telix”) is...
Read More →
Melbourne, Australia, Sept. 18, 2017 – Telix Pharmaceuticals Limited (“Telix”) is pleased to announce that...
Read More →
Melbourne, Australia, July 31, 2017 – Telix Pharmaceuticals Limited (“Telix”) is pleased to announce the...
Read More →
Melbourne, Australia and Cambridge, UK, July. 18, 2017 – Telix Pharmaceuticals Limited (“Telix”) is pleased...
Read More →
Melbourne, Australia and Dresden, Germany, Jan. 18, 2017 – Telix Pharmaceuticals Limited (“Telix”) is pleased...
Read More →
Melbourne, Australia and Nantes, France, Jan. 18, 2017 – Telix Pharmaceuticals Limited (“Telix”) is pleased...
Read More →
Telix receives exclusive worldwide rights for the development and commercialization of diagnostic agent REDECTANE® (INN:...
Read More →